JP2003292459A5 - - Google Patents

Download PDF

Info

Publication number
JP2003292459A5
JP2003292459A5 JP2003059191A JP2003059191A JP2003292459A5 JP 2003292459 A5 JP2003292459 A5 JP 2003292459A5 JP 2003059191 A JP2003059191 A JP 2003059191A JP 2003059191 A JP2003059191 A JP 2003059191A JP 2003292459 A5 JP2003292459 A5 JP 2003292459A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003059191A
Other languages
Japanese (ja)
Other versions
JP2003292459A (ja
JP4740524B2 (ja
Filing date
Publication date
Priority claimed from TW91101510A external-priority patent/TWI299667B/zh
Priority claimed from CNB021032564A external-priority patent/CN1224424C/zh
Application filed filed Critical
Publication of JP2003292459A publication Critical patent/JP2003292459A/ja
Publication of JP2003292459A5 publication Critical patent/JP2003292459A5/ja
Application granted granted Critical
Publication of JP4740524B2 publication Critical patent/JP4740524B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003059191A 2002-01-30 2003-01-29 熱応答粘膜接着性医薬−担体組成物 Expired - Lifetime JP4740524B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TW091101510 2002-01-30
TW91101510A TWI299667B (en) 2002-01-30 2002-01-30 A mucoadhesive thermoresponsive medicament-carrier composition
CNB021032564A CN1224424C (zh) 2002-02-01 2002-02-01 粘膜吸附性的热凝性医药载体组合物

Publications (3)

Publication Number Publication Date
JP2003292459A JP2003292459A (ja) 2003-10-15
JP2003292459A5 true JP2003292459A5 (enExample) 2005-10-27
JP4740524B2 JP4740524B2 (ja) 2011-08-03

Family

ID=30116452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003059191A Expired - Lifetime JP4740524B2 (ja) 2002-01-30 2003-01-29 熱応答粘膜接着性医薬−担体組成物

Country Status (2)

Country Link
US (2) US20040009212A1 (enExample)
JP (1) JP4740524B2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5010920B2 (ja) 2003-11-08 2012-08-29 プロセラ・バイオロジクス 治療に使用するためのヒト血漿由来のインターα阻害タンパク質の調製方法及びその組成物
ATE490465T1 (de) * 2005-01-28 2010-12-15 Childrens Medical Center Diagnose- und prognoseverfahren von blasenkrebs.
US7851189B2 (en) * 2005-03-07 2010-12-14 Boston Scientific Scimed, Inc. Microencapsulated compositions for endoluminal tissue engineering
WO2006133349A2 (en) * 2005-06-08 2006-12-14 Alpharma, Inc. Orally disintegrable sleep aid formulations
WO2007136633A2 (en) * 2006-05-18 2007-11-29 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
US20080279921A1 (en) * 2007-05-07 2008-11-13 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
WO2009073457A1 (en) * 2007-11-30 2009-06-11 Bausch & Lomb Incorporated Methods and compositions for the rescue of a filtering bleb
PT2291654T (pt) * 2008-05-28 2018-06-15 Prothera Biologics Inc Preparação e composição de proteínas inibidoras de interalfa do sangue
KR100935711B1 (ko) 2008-09-12 2010-01-07 김희구 생약 패드
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
MX2011013127A (es) * 2009-06-11 2012-02-21 Photocure Asa Composiciones semi-solidas y productos farmaceuticos.
WO2011004011A1 (en) 2009-07-10 2011-01-13 Thrombogenics Nv Variants of plasminogen and plasmin
WO2011023805A1 (en) 2009-08-28 2011-03-03 Thrombogenics N.V. Use of plasmin for the treatment of filtration failure after trabeculectomy
HUE040119T2 (hu) 2009-10-01 2019-02-28 Adare Pharmaceuticals Inc Orálisan alkalmazott kortikoszteroid készítmények
DE212011100034U1 (de) * 2010-01-20 2012-07-04 Theracoat Ltd. Material zur Behandlung von inneren Hohlräumen
US10471150B2 (en) 2010-01-20 2019-11-12 Urogen Pharma Ltd. Material and method for treating internal cavities
CN103384722B (zh) 2011-01-05 2016-11-16 斯路姆基因公司 纤溶酶原和纤溶酶变体
WO2012135422A2 (en) * 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
EP2734187B1 (en) * 2011-07-20 2018-09-05 UroGen Pharma Ltd. Materials and method for treating internal body cavities
CA2844644A1 (en) 2011-08-12 2013-02-21 Thrombogenics N.V. Plasminogen and plasmin variants
RU2635466C2 (ru) * 2012-04-08 2017-11-13 Теракоат Лтд Препараты термообратимого гидрогеля для применения при лечении нарушений уротелия
FR2994844B1 (fr) * 2012-08-31 2015-01-02 Assist Publ Hopitaux De Paris Formulation gelifiante a base de ketamine
US9572872B2 (en) 2012-09-09 2017-02-21 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
US9801854B1 (en) * 2014-01-17 2017-10-31 Urogen Pharma Ltd. Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer
AR100864A1 (es) * 2014-06-09 2016-11-09 Klox Tech Inc Composiciones biofotónicas termoendurecibles y sus usos
AP2017009684A0 (enExample) 2014-08-11 2017-01-31
DE102016001176A1 (de) * 2016-02-03 2017-08-03 Audi Ag Kraftfahrzeug
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
EP3512539A4 (en) 2016-09-13 2020-07-29 Prothera Biologics, Inc. METHODS FOR TREATING LUNG DISEASE USING INTER-ALPHA INHIBITOR PROTEINS
AU2018258466B2 (en) 2017-04-25 2025-05-22 Prothera Biologics, Inc. Methods for quantifying inter-alpha inhibitor proteins
WO2019217536A1 (en) 2018-05-08 2019-11-14 University Of Connecticut Long-acting local anesthetic formulation
US20210236657A1 (en) * 2018-08-06 2021-08-05 Oregon Health & Science University Nerve-specific fluorophore formulations for direct and systemic administration
JP7064612B2 (ja) * 2018-09-20 2022-05-10 富士フイルム株式会社 生体材料
CN112043827B (zh) * 2019-05-20 2023-10-20 复旦大学 温敏性药物组合物、透皮制剂及其制备方法和应用
EP4259093B1 (en) 2020-12-11 2025-08-13 UroGen Pharma Ltd. Material and method for treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
CA2158724A1 (en) * 1994-09-20 1996-03-21 Jue-Chen Liu Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
US6280745B1 (en) * 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
DE19744811C2 (de) * 1997-10-02 1999-11-18 Medac Klinische Spezialpraep Verwendung von delta-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
HU229441B1 (en) * 1999-01-08 2013-12-30 3M Innovative Properties Co Formulations and methods for treating mucosal associated conditions with an immune response modifier
US6333194B1 (en) * 1999-01-19 2001-12-25 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof

Similar Documents

Publication Publication Date Title
BE2013C075I2 (enExample)
BE2013C070I2 (enExample)
BE2013C067I2 (enExample)
BE2013C038I2 (enExample)
BE2013C036I2 (enExample)
JP2003310537A5 (enExample)
BE2011C030I2 (enExample)
IN2004MU00746A (enExample)
BE2013C034I2 (enExample)
JP2003292459A5 (enExample)
JP2004221348A5 (enExample)
BE2012C053I2 (enExample)
JP2003299632A5 (enExample)
JP2003247632A5 (enExample)
JP2004087457A5 (enExample)
JP2003323159A5 (enExample)
JP2004029736A5 (enExample)
JP2004221218A5 (enExample)
DE602004032111D1 (enExample)
JP2004206041A5 (enExample)
JP2004149216A5 (enExample)
JP2003245772A5 (enExample)
JP2003199955A5 (enExample)
AU2002359010A1 (enExample)
AU2003207750A1 (enExample)